LONA is LeonaBio, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $7.56. Market cap: $71M.
Stock snapshot
| Price | $7.56 |
| Market cap | $71M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About LONA
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Related non-dividend companies
Other non-dividend stocks investors research alongside LONA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LONA's current stock price?
LONA (LeonaBio, Inc.) is currently trading at $7.56.
Does LONA pay a dividend?
LONA (LeonaBio, Inc.) does not currently pay a regular dividend.
Track LONA in DiviDrip
Add LONA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LONA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.